Skip to main content

Contraceptive Care - Postpartum

CBE ID
2902
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Among women ages 15 through 44 who had a live birth, the percentage that is provided:
1) A most effective (i.e., sterilization, implants, intrauterine devices or systems (IUD/IUS)) or moderately (i.e., injectables, oral pills, patch, or ring) effective method of contraception within 3 and 60 days of delivery.

2) A long-acting reversible method of contraception (LARC) within 3 and 60 days of delivery.

Two time periods are proposed (i.e., within 3 and within 60 days of delivery) because each reflects important clinical recommendations from the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG). The 60-day period reflects ACOG recommendations that women should receive contraceptive care at the 6-week postpartum visit. The 3-day period reflects CDC and ACOG recommendations that the immediate postpartum period (i.e., at delivery, while the woman is in the hospital) is a safe time to provide contraception, which may offer greater convenience to the client and avoid missed opportunities to provide contraceptive care.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Numerator

    Primary measure: Women ages 15 through 44 who had a live birth and were provided a most (sterilization, implant, intrauterine device) or moderately (injectable, pill, patch, or ring) effective method of contraception within 3 and 60 days of delivery.

    Sub-measure: Women ages 15 through 44 who had a live birth and were provided a long-acting reversible method of contraception (LARC) within 3 and 60 days of delivery.

    Denominator

    Women ages 15 through 44 who had a live birth in a 12-month measurement year.

    Exclusions

    The following categories are excluded from the denominator: (1) deliveries that did not end in a live birth (i.e., miscarriage, ectopic, stillbirth or induced abortion); and (2) deliveries that occurred during the last two months of the measurement year.

    Testing Data Sources
  • Most Recent Endorsement Activity
    Endorsed Perinatal and Women's Health Spring 2021
    Initial Endorsement
    Next Planned Maintenance Review
    Perinatal and Women's Health Spring 2025
    Endorsement Status
    Last Updated